SF Holding(SZ:002352) Chang Jiang Shang Bao·2025-11-21 00:01Core Insights - SF Holding reported a total revenue of 26.454 billion yuan in October 2025, representing a year-on-year growth of 9.79% [2][3] - The express logistics business volume reached 1.524 billion packages in October, a year-on-year increase of 26.26%, marking a historical high for the company [4][5] - The company continues to implement its "activation operation" mechanism to enhance market expansion and improve service competitiveness [4][6] Revenue Breakdown - In October, the express logistics business generated revenue of 20.091 billion yuan, up 13.68% year-on-year, while the supply chain and international business revenue was 6.363 billion yuan, showing a slight decline of 0.93% [3][4] - The average revenue per package decreased to 13.18 yuan, down 9.97% year-on-year, compared to 16.26 yuan in October 2023, indicating a decline of approximately 19% over two years [4][5] Market Context - The logistics industry is experiencing steady growth, supported by national policies aimed at reducing costs and improving efficiency [2][4] - The overall postal industry reported a cumulative business volume of 177.25 billion items in the first ten months of 2025, with express delivery volume reaching 162.68 billion items, reflecting a year-on-year growth of 16.1% [2] Strategic Initiatives - SF Holding is focusing on sustainable development and high-quality service to meet the increased demand during peak shopping seasons [4][6] - The company is adapting to market changes by leveraging its global network and product offerings, particularly in international freight and supply chain services [4][6] Future Outlook - The company anticipates steady growth in net profit for 2025, despite short-term pressure on profitability due to pricing declines [6][7] - SF Holding aims to maintain a stable net profit in the fourth quarter of 2025 and continue to strengthen its strategic position in the logistics market [7][8] Partnerships and Collaborations - In October, SF Holding established a strategic partnership with Zeiss for global distribution and collaborated with Meituan Health to enhance its pharmaceutical supply chain capabilities [9]